Related Experiment Videos
Update on lung transplantation in children
J W Gaynor1, N D Bridges, B J Clark
1Children's Hospital of Philadelphia, PA 19104, USA.
Insights
Pediatric lung transplantation offers improved early outcomes for children with severe lung diseases. However, long-term challenges like infections and donor shortages persist, impacting treatment accessibility.
Area of Science:
- Pediatric pulmonology
- Thoracic surgery
- Transplant medicine
Background:
- Lung transplantation is a critical intervention for pediatric patients suffering from acquired and congenital pulmonary conditions.
- Key indications include pulmonary hypertension, bronchopulmonary dysplasia, pulmonary vein stenosis, and cystic fibrosis.
Purpose of the Study:
- To review the current status of lung transplantation in children.
- To highlight advancements in early outcomes and persistent long-term challenges.
Main Methods:
- This review synthesizes current literature on pediatric lung transplantation.
- Focuses on indications, early outcomes, long-term complications, and donor availability.
Main Results:
- Early outcomes following pediatric lung transplantation have significantly improved.
- Persistent long-term complications include infections, bronchiolitis obliterans, and immunosuppression-related issues.
- Donor availability, particularly for neonates, remains a significant limitation.
Conclusions:
- Pediatric lung transplantation is a viable option with improving early results.
- Addressing long-term complications and donor scarcity is crucial for expanding this life-saving treatment.
Abstract:
Lung transplantation is an important treatment option in children with acquired and congenital pulmonary disease. Indications for lung transplantation include pulmonary hypertension, bronchopulmonary dysplasia, pulmonary vein stenosis, and cystic fibrosis. The early outcome following lung transplantation has improved considerably. Longterm complications, however, including infections, bronchiolitis obliterans, and complications of immunosuppression remain significant problems. Donor availability, especially for neonates, continues to limit the utilization of lung transplantation.